Cardiovascular disease (CVD) is the leading cause of death in Europe. For decades, public health strategies have focused on ...
Healthcare Trend Analysis Reveals Shift Toward Non-Invasive Pre-Surgical Evaluation as Multi-Modal Compression Technology Addresses Growing Patient Demand for Evidence-Based Alternatives ...
RetinalGenix Technologies Inc.[OTCQB: RTGN] ('RetinalGenix” or the 'Company”), a company developing ultra-high-resolution ...
Key Players in the Renal Denervation Devices Market are Medtronic plc, Recor Medical Inc., Johnson & Johnson, Boston ...
Dr. Rothstein brings more than four decades of clinical, academic, and leadership experience in emergency medicine, mental ...
Lapsi Health launched the second generation of its digital smart stethoscope that integrates an AI medical scribe. | Lapsi ...
RetinalGenix Technologies Inc. [OTCQB: RTGN] ("RetinalGenix" or the "Company"), a company developing ultra-high-resolution retinal imaging technology ...
Depression affects 300+ million people and increases the risk of cardiovascular disease (CVD) and mortality by two to three times.- One ...
The global Dental Implant Market was valued at USD 5.2 billion in 2024 and is projected to reach USD 8.4 billion by 2033, ...
Growing adoption in chronic disease management, telemedicine, and emerging healthcare markets positions portable ultrasound ...
Edwards Lifesciences remains a market leader in transcatheter heart valve technologies, with strong secular tailwinds and ...
Abbott’s strong Q3, global diversification, and resilient portfolio support long-term growth despite diagnostics softness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback